Tiotropium Bromide and Olodaterol Hydrochloride
- Generic Name
- Tiotropium Bromide and Olodaterol Hydrochloride
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于慢阻肺的维持治疗。
- Associated Conditions
- -
- Associated Therapies
- -
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 4819
- Registration Number
- NCT03663569
- Locations
- 🇧🇬
MBAL Kiro Popov EOOD, Karlovo, Bulgaria
🇧🇬MBAL Sv. Ivan Rilski EOOD, Kozloduj, Bulgaria
🇧🇬MBAL Sliven to VMA Sofia, Sliven, Bulgaria
Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1335
- Registration Number
- NCT02850978
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath